Aromatase Inhibitors Plus Weight Loss Improves the Hormonal Profile of Obese Hypogonadal Men Without Causing Major Side Effects

Objective: In obese men, the increased expression of the aromatase enzyme in adipose tissue leads to high conversion of androgens to estrogens contributing to hypogonadotropic hypogonadism (HHG). Our objective is to evaluate efficacy and safety of weight loss (WL) plus aromatase inhibitor (AI) thera...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Front Endocrinol (Lausanne)
Главные авторы: Colleluori, Georgia, Chen, Rui, Turin, Christie G., Vigevano, Francesca, Qualls, Clifford, Johnson, Biju, Mediwala, Sanjay, Villareal, Dennis T., Armamento-Villareal, Reina
Формат: Artigo
Язык:Inglês
Опубликовано: Frontiers Media S.A. 2020
Предметы:
Endocrinology
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7243137/
https://ncbi.nlm.nih.gov/pubmed/32499757
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fendo.2020.00277
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы